Evaluation of the effectiveness of remimazolam for anesthesia in the hepatectomy

Evaluation of the effectiveness of remimazolam for anesthesia in the hepatectomy - Evaluation of the effectiveness of remimazolam for anesthesia in the hepatectomy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000040901

Enrollment

Registered

2020-06-30

Start date

2020-06-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients scheduled for hepatectomy under general anesthesia

Interventions

General anesthesia with remimazolam Continuous infusion of remimazolam from the induction of general anesthesia to the end of surgery

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients scheduled for hepatectomy under general anesthesia

Exclusion criteria

Exclusion criteria: Patients with disturbance of consciousness Patients with drug dependence Patients with uncontrolled hypertension Patients with acute angle-closure glaucoma Pregnant women Lactating women Patients with myasthenia graves Patients with severe liver dysfunction End-stage renal failure or dialysis patients Patients with alcoholism Emergency surgery

Design outcomes

Primary

Measure	Time frame
Time from the end of anesthetic administration to awaking and extubation	—

Countries

Japan

Contacts

Public ContactKenichiro Kikuchi

Sapporo Medical University Department of Anesthesiology

flybabrfr@live.jp011-611-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026